{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:29:41Z","timestamp":1786444181329,"version":"build-2736575974"},"reference-count":57,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Operational Program Integrated Infrastructure","award":["313011V344"],"award-info":[{"award-number":["313011V344"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Metabolic syndrome (MetS) is associated with increased cardiometabolic risk, although substantial metabolic abnormalities may also occur in individuals with normal body weight. This study compared anthropometric characteristics, body composition, lipid profile, LDL subfractions, inflammatory markers, liver biomarkers, and novel cardiometabolic indices in participants with MetS according to obesity status and characterized the metabolic phenotype of normal-weight participants with MetS. Methods: This cross-sectional study included 188 Slovak adults. Anthropometric, biochemical, lipoprotein, inflammatory, liver function, and cardiometabolic parameters were assessed. Group differences were analyzed using the Mann\u2013Whitney U test, and associations were evaluated by Spearman\u2019s correlation analysis. Results: Compared with controls, participants with MetS had significantly greater adiposity, visceral fat accumulation, atherogenic lipid alterations, elevated inflammatory and liver biomarkers, higher blood pressure, and increased cardiometabolic indices (p &lt; 0.05). Within the MetS group, overweight\/obese participants exhibited greater visceral adiposity and higher liver enzyme concentrations, whereas most lipid parameters, LDL subfraction distribution, and several cardiometabolic indices were comparable between weight groups. VAI, TyG, TyG-BMI, TyG-WC, TyG-WHtR, LAP, AIP, and CMI showed strong correlations with visceral adiposity, triglycerides, atherogenic LDL subfractions, and smaller LDL particle size. Conclusions: Obesity worsens body composition and hepatic dysfunction in MetS but has limited impact on several metabolic and atherogenic characteristics. LDL-C concentration alone may not sufficiently reflect the true atherogenic risk. These findings support the metabolically unhealthy normal-weight phenotype and highlight the value of novel cardiometabolic indices and LDL subfraction analysis for improved cardiometabolic risk assessment.<\/jats:p>","DOI":"10.3390\/metabo16080567","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:11:16Z","timestamp":1786439476000},"page":"567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers in Obesity-Related Metabolic Syndrome: Relationships Between LDL Subfractions, Lipid Profile, and Cardiometabolic Risk in a Slovak Population"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-7311","authenticated-orcid":false,"given":"Martina","family":"Ga\u017earov\u00e1","sequence":"first","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-7191","authenticated-orcid":false,"given":"Petra","family":"Len\u00e1rtov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"\u017demberyov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Civ\u00e1\u0148ov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ha\u010dkov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Kijovsk\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"\u0160ubov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Trieda Andreja Hlinku 2, 949 76 Nitra, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8805-186X","authenticated-orcid":false,"given":"Magdalena","family":"G\u00f3rnicka","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition Science, Department of Human Nutrition, Warsaw University of Life Science, Nowoursynowska 159 St., Bldg. 32, Room 2\/2110, 02-766 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ambroselli, D., Masciulli, F., Romano, E., Catanzaro, G., Besharat, Z.M., Massari, M.C., Ferretti, E., Migliaccio, S., Izzo, L., and Ritieni, A. (2023). New advances in metabolic syndrome, from prevention to treatment: The role of diet and food. Nutrients, 15.","DOI":"10.3390\/nu15030640"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s10020-024-01019-y","article-title":"The interplay of factors in metabolic syndrome: Understanding its roots and complexity","volume":"30","author":"Islam","year":"2024","journal-title":"Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13098-025-01903-5","article-title":"Narrative review of metabolic syndrome and its relationships with non-alcoholic fatty liver disease, gonadal dysfunction and obstructive sleep apnea","volume":"17","author":"Reda","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"18684","DOI":"10.1038\/s41598-024-69486-1","article-title":"Association of weight-adjusted waist index with cardiovascular disease and mortality among metabolic syndrome population","volume":"14","author":"Tao","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11154-024-09879-9","article-title":"Ethnic differences in metabolic syndrome in high-income countries: A systematic review and meta-analysis","volume":"25","author":"Adjei","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ma, K., Liu, H., Guo, L., Li, J., Lei, Y., Li, X., Sun, L., Yang, L., Yuan, T., and Wang, C. (2024). Comparison of metabolic syndrome prevalence and characteristics using five different definitions in China: A population-based retrospective study. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1333910"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bowo-Ngandji, A., Kenmoe, S., Ebogo-Belobo, J.T., Kenfack-Momo, R., Takuissu, G.R., Kengne-Nd\u00e9, C., Mbaga, D.S., Tchatchouang, S., Kenfack-Zanguim, J., and Lontuo Fogang, R. (2023). Prevalence of the metabolic syndrome in African populations: A systematic review and meta-analysis. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0289155"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1038\/s41598-024-62497-y","article-title":"Prevalence of metabolic syndrome among people living with human immunodeficiency virus in sub-Saharan Africa: A systematic review and meta-analysis","volume":"14","author":"Asgedom","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/s41598-022-19690-8","article-title":"Hypertriglyceridemic-waist phenotype is strongly associated with cardiovascular risk factor clustering in Chinese adolescents","volume":"12","author":"Cai","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116116","DOI":"10.1016\/j.bcp.2024.116116","article-title":"The pathophysiology of visceral adipose tissues in cardiometabolic diseases","volume":"222","author":"Lee","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_12","first-page":"2","article-title":"Lipids, lipoproteins, atherosclerosis and cardiovascular disease","volume":"25","author":"Burnett","year":"2004","journal-title":"Clin. Biochem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clinbiochem.2015.01.011","article-title":"Small-dense LDL\/large-buoyant LDL ratio associates with the metabolic syndrome","volume":"48","author":"Srisawasdi","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1273042","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11154-023-09834-0","article-title":"Childhood obesity, metabolic syndrome, and oxidative stress: MicroRNAs go on stage","volume":"24","author":"Belmonte","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4070\/kcj.2021.0328","article-title":"Lifestyle modification in the management of metabolic syndrome: Statement from Korean Society of Cardiometabolic Syndrome (KSCMS)","volume":"52","author":"Kim","year":"2022","journal-title":"Korean Circ. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-025-02591-1","article-title":"The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: Insights from NHANES data with machine learning analysis","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17019","DOI":"10.1038\/s41598-025-01549-3","article-title":"Association between triglyceride glucose body mass index and 1-year all-cause mortality in stage 4 CKM syndrome patients","volume":"15","author":"Pan","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zheng, Z., Yin, X., Liu, J., and Zhang, Y. (2026). Triglyceride-glucose index and its derivatives as emerging biomarkers of insulin resistance for prognostic evaluation of cardiovascular-kidney-metabolic syndrome: Mechanisms and clinical applications. Front. Pharmacol., 17.","DOI":"10.3389\/fphar.2026.1787130"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinre.2019.04.002","article-title":"The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study","volume":"44","author":"Okamura","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl19301","article-title":"Hepatic steatosis index in the detection of fatty liver in patients with chronic hepatitis B receiving antiviral therapy","volume":"15","author":"Chang","year":"2021","journal-title":"Gut Liver"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1373\/clinchem.2004.033175","article-title":"Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: Theoretical and practical implications","volume":"50","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12944-018-0656-1","article-title":"Atherogenic index of plasma is an effective index for estimating abdominal obesity","volume":"17","author":"Shen","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, F., Niu, Y., Wu, R., Jiang, H., Zhu, J., Wang, C., Xia, X., and Jin, Y. (2025). Association between cardiometabolic index and cardiovascular disease: Evidence from the NHANES 2007\u20132018. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1516591"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.numecd.2023.01.015","article-title":"New indices in predicting cardiometabolic risk and its relation to endothelial dysfunction in adolescents: The HELENA study","volume":"33","author":"Nogueira","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-013-9252-x","article-title":"Metabolically healthy obesity: Definitions, determinants and clinical implications","volume":"14","author":"Phillips","year":"2013","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lin, Z., and Sun, L. (2024). Research advances in the therapy of metabolic syndrome. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1364881"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.32394\/rpzh\/213375","article-title":"Normal weight obesity\u2014Hidden obesity behind a normal BMI: Application of composite body composition indices in nutritional status evaluation in Slovak females","volume":"76","year":"2025","journal-title":"Rocz. Panstw. Zakl. Hig."},{"key":"ref_32","first-page":"19","article-title":"Investigating Nutritional and Health Dynamics across Stratified Profiles of Obesity","volume":"1","author":"Azor","year":"2025","journal-title":"Cent. Eur. J. Sport Sci. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2478\/v10044-008-0004-6","article-title":"Assessment of the BMI, WHR and W\/Ht in pre- and postmenopausal women","volume":"70","author":"Skrzypczak","year":"2007","journal-title":"Anthropol. Rev."},{"key":"ref_35","unstructured":"Mu\u00f1iz, N., Nu\u00f1ez, E., Rivera, M., and Ban, M. (2026, May 16). LDL Subfractions Analysis in Pro-Atherogenic Dyslipidemia. Quantimetrix, Redondo Beach, CA, USA. Available online: https:\/\/quantimetrix.com\/wp-content\/uploads\/Quantimetrix_Lipoprint_poster.pdf."},{"key":"ref_36","first-page":"1","article-title":"Biomarkers of dysfunctional visceral fat","volume":"109","author":"Gugliucci","year":"2022","journal-title":"Adv. Clin. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Giangregorio, F., Mosconi, E., Debellis, M.G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., Kaloudi, O., Mustafazade, G., and Mar\u00edn-Baselga, R. (2024). A systematic review of metabolic syndrome: Key correlated pathologies and non-invasive diagnostic approaches. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195880"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11906-024-01295-3","article-title":"Hyperuricemia: An intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension","volume":"26","author":"Vareldzis","year":"2024","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: An update","volume":"126","year":"2012","journal-title":"Circulation"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diabetes.47.5.699","article-title":"The metabolically obese, normal-weight individual revisited","volume":"47","author":"Ruderman","year":"1998","journal-title":"Diabetes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41574-024-01008-5","article-title":"Metabolically healthy obesity: From epidemiology and mechanisms to clinical implications","volume":"20","author":"Schulze","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102635","DOI":"10.1016\/j.dsx.2022.102635","article-title":"Metabolically unhealthy phenotype in normal weight population and risk of mortality and major adverse cardiac events: A meta-analysis of 41 prospective cohort studies","volume":"16","author":"Putra","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.metabol.2006.02.015","article-title":"Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria","volume":"55","author":"Gazi","year":"2006","journal-title":"Metabolism"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/nu5030928","article-title":"Lipoprotein subfractions in metabolic syndrome and obesity: Clinical significance and therapeutic approaches","volume":"5","author":"Nikolic","year":"2013","journal-title":"Nutrients"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.694","article-title":"Small, dense low-density lipoproteins and the metabolic syndrome","volume":"23","author":"Rizzo","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_48","first-page":"4678526","article-title":"Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review","volume":"2020","author":"Solis","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_49","first-page":"44","article-title":"Triglyceride-glucose index as a biomarker of insulin resistance, diabetes mellitus, metabolic syndrome, and cardiovascular disease: A review","volume":"35","author":"Kurniawan","year":"2024","journal-title":"EJIFCC"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Er, L.K., Wu, S., Chou, H.H., Hsu, L.A., Teng, M.S., Sun, Y.C., and Ko, Y.L. (2016). Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149731"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of diabetic dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhuo, L., Lai, M., Wan, L., Zhang, X., and Chen, R. (2024). Cardiometabolic index and the risk of new-onset chronic diseases: Results of a national prospective longitudinal study. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1446276"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s13098-025-01912-4","article-title":"The association between cardiometabolic index (CMI) and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis","volume":"17","author":"Azarboo","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13105-020-00781-x","article-title":"Metabolically healthy obesity and metabolically obese normal weight: A review","volume":"77","author":"Queralt","year":"2021","journal-title":"J. Physiol. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/ndt\/gft029","article-title":"Uric acid and chronic kidney disease: Which is chasing which?","volume":"28","author":"Johnson","year":"2013","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/8\/567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:36:46Z","timestamp":1786441006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/8\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["metabo16080567"],"URL":"https:\/\/doi.org\/10.3390\/metabo16080567","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}